Stoxtel (https://www.stoxtel.net/) has officially unveiled the technical specifications of its proprietary “Matrix” Trading ...

Closing the C-UAS Rules of Engagement (ROE) Gap, we established a critical reality: While Counter-Uncrewed Aircraft Systems ...

Learn how retrospectively rated insurance adjusts premiums based on actual losses, the benefits it offers, and how it compares to experience-rated insurance.

Cancer’s most catastrophic DNA damage has long looked like a crime scene without a culprit, with chromosomes shattered and reassembled in ways that defy normal biology. Now researchers say they have ...

Labeling adversary activity with ATT&CK techniques is a tried-and-true method for classifying behavior. But it rarely tells defenders how those behaviors are executed in real environments.

Solve Intelligence, the AI platform for the $200B+ patent industry, has raised $40M in Series B funding and is launching a new product for generating patent claim charts. Solve’s Series B comes just ...

Changing your class in The Forge isn’t as simple as picking the one you want — it all comes down to rerolls and luck. In this guide, we break down every method you can use to reroll your race so you ...

SAN DIEGO--(BUSINESS WIRE)--Solve Therapeutics, a clinical-stage biotechnology company developing best-in-class antibody-drug conjugates (ADCs) for solid tumor malignancies, today announced it has ...

A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts. Solve Therapeutics’ ...

Funding round was led by Yosemite, with participation from new investors Abingworth, Ally Bridge Group, B Capital, Balyasny Asset Management, Merck & Co., SymBiosis, and all existing investors Solve ...